Skip to main content
. 2020 Apr 30;24(2):137–142. doi: 10.4103/ijem.IJEM_588_19

Figure 1.

Figure 1

The overall survival (OS) at 3 years was 92.31% (SE 7.3%, 95% CI 56.64–98.88%)